M/S. MYLAN PHARMACEUTICALS INC, Pantoprazole Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Pantoprazole from India and how much does M/S. MYLAN PHARMACEUTICALS INC, import?

India exports Pantoprazole to 1,893 buyers globally worth $113.6M. M/S. MYLAN PHARMACEUTICALS INC, imports $2.3M (0.1% market share) with 48 shipments from UNITED STATES.

Q: What is the average order value for M/S. MYLAN PHARMACEUTICALS INC,'s Pantoprazole imports?

M/S. MYLAN PHARMACEUTICALS INC,'s average Pantoprazole order value is $47.1K per consignment, based on 48 shipments totaling $2.3M.

Q: Who supplies Pantoprazole to M/S. MYLAN PHARMACEUTICALS INC,?

M/S. MYLAN PHARMACEUTICALS INC, sources Pantoprazole from 1 verified supplier: MYLAN LABORATORIES LIMITED ($2.3M, 100.0%). Based on 48 customs records.

Q: How does M/S. MYLAN PHARMACEUTICALS INC, compare to other Pantoprazole importers?

M/S. MYLAN PHARMACEUTICALS INC, ranks #14 among 1,893 Pantoprazole importers from India with 0.1% market share and 48 shipments.

Q: Who are the top Pantoprazole importers from India?

Top Pantoprazole importers: APL SWIFT SERVICES (MALTA) LTD., ($50.9M), YUSEN LOGISTICS BENELUX BELGIUM ($15.9M), TORRENT PHARMA INC ($8.4M), EUGIA US LLC ($7.7M), MYLAN PHARMACEUTICALS INC, ($5.7M).

Suresh Sormare

Pantoprazole

India Pharmaceutical Trade Intelligence

$1.3B744 Suppliers154 CountriesHS 30049039

ExportsIndia → UNITED STATES68.3%India → MALTA12.6%

ImportsGERMANY → India$152.4K BRAZIL → India$68.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

M/S. MYLAN PHARMACEUTICALS INC, — Pantoprazole Importer #14 | $2.3M Trade Value | TransData Nexus | TransData Nexus

M/S. MYLAN PHARMACEUTICALS INC, — Pantoprazole Importer Profile

Pharmaceutical Importer · #14 buyer for Pantoprazole · $2.3M import value · 48 shipments · UNITED STATES · DGFT Verified

M/S. MYLAN PHARMACEUTICALS INC, is the #14 importer of Pantoprazole from India with $2.3M in import value and 48 verified shipments. M/S. MYLAN PHARMACEUTICALS INC, holds a 0.1% market share in Pantoprazole imports based in UNITED STATES. The company sources from 1 verified supplier across 7 formulations shipped to 2 countries. Overall, M/S. MYLAN PHARMACEUTICALS INC, imports 9 pharmaceutical products worth $8.0M across 7 therapeutic categories.

M/S. MYLAN PHARMACEUTICALS INC, — Pantoprazole Import Profile: Suppliers, Formulations & Sources

M/S. MYLAN PHARMACEUTICALS INC, — Pantoprazole import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Pantoprazole to M/S. MYLAN PHARMACEUTICALS INC,?

Verified from 48 customs shipment records

Supplier	Value	Shipments	% Share
MYLAN LABORATORIES LIMITED	$2.3M	48	100.0%

M/S. MYLAN PHARMACEUTICALS INC, sources Pantoprazole from 1 verified Indian supplier based on 48 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.

How Does M/S. MYLAN PHARMACEUTICALS INC, Compare to Nearest Pantoprazole Importers?

Buyers ranked immediately above and below #14 by import value

#	Buyer

Where Does M/S. MYLAN PHARMACEUTICALS INC, Import Pantoprazole To?

Destination countries from 48 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$1.7M	37	75.7%
CANADA	$550.0K	11	24.3%

M/S. MYLAN PHARMACEUTICALS INC, imports Pantoprazole to 2 countries. The primary destination is UNITED STATES receiving 75.7% of shipments worth $1.7M.

What Pantoprazole Formulations Does M/S. MYLAN PHARMACEUTICALS INC, Import?

Formulation	Value	Shipments
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL	$1.2M	26
PANTOPRAZOLE SODIUM DELAYED RELEASE TABL	$518.2K	11
SANIS PANTOPRAZOLE T 40 MG 100 BT TAB PA	$250.0K	5
MYLAN PANTOPRAZOLE T 40 MG TAB 100 BT PA	$150.0K	3
PANTOPRAZOLE T 40 MG 100 BT TAB PACKS 52	$50.0K	1
PANTOPRAZOLE T 40 MG 100BT TAB PACKS 522	$50.0K	1
SANIS PANTOPRAZOLE T 40 100 BT TAB PACKS	$50.0K	1

M/S. MYLAN PHARMACEUTICALS INC, imports 7 distinct Pantoprazole formulations from India. The top formulation is PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL with 26 shipments worth $1.2M.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pantoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: M/S. MYLAN PHARMACEUTICALS INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as M/S. MYLAN PHARMACEUTICALS INC,'s capped import value divided by total capped export value for Pantoprazole across all Indian exporters.
5.Verified Records: This page is backed by 48 individual customs records matching M/S. MYLAN PHARMACEUTICALS INC, importing Pantoprazole, covering 7 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 154+ countries, 1,893+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pantoprazole

Pantoprazole

M/S. MYLAN PHARMACEUTICALS INC, — Pantoprazole Importer Profile

M/S. MYLAN PHARMACEUTICALS INC, — Pantoprazole Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Pantoprazole to M/S. MYLAN PHARMACEUTICALS INC,?

How Does M/S. MYLAN PHARMACEUTICALS INC, Compare to Nearest Pantoprazole Importers?

Where Does M/S. MYLAN PHARMACEUTICALS INC, Import Pantoprazole To?

What Pantoprazole Formulations Does M/S. MYLAN PHARMACEUTICALS INC, Import?

Regulatory Requirements: Importing Pantoprazole into United States

Regulatory Authority

Approval Process for Generic Pantoprazole

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Pantoprazole from India and How Much Does M/S. MYLAN PHARMACEUTICALS INC, Import?

What Is the Average Order Value for M/S. MYLAN PHARMACEUTICALS INC,'s Pantoprazole Imports?

Who Supplies Pantoprazole to M/S. MYLAN PHARMACEUTICALS INC,?

How Does M/S. MYLAN PHARMACEUTICALS INC, Compare to Other Pantoprazole Importers?

About M/S. MYLAN PHARMACEUTICALS INC,

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pantoprazole Import Data for M/S. MYLAN PHARMACEUTICALS INC,

M/S. MYLAN PHARMACEUTICALS INC, × Pantoprazole

Company Overview

Top Products by M/S. MYLAN PHARMACEUTICALS INC,

Related Analysis

Need Detailed Import Data?

Data Source

7	MYLAN PHARMACEUTICALS ULC,	CANADA	$1.9M	39	$50.0K
12	AUROLOGISTICS LLC (AUROMEDICS PHARM	UNITED STATES	$1.9M	39	$50.0K
14	M/S. MYLAN PHARMACEUTICALS INC, ★	UNITED STATES	$1.9M	37	$50.0K
17	MYLAN PHARMACEUTICALS ULC	CANADA	$1.4M	28	$50.0K